- Home
- UIS vs LRMR Comparison
UIS vs LRMR Comparison
Compare UIS & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UIS
- LRMR
- Stock Information
- Founded
- UIS 1942
- LRMR N/A
- Country
- UIS United States
- LRMR United States
- Employees
- UIS N/A
- LRMR N/A
- Industry
- UIS EDP Services
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- UIS Technology
- LRMR Health Care
- Exchange
- UIS Nasdaq
- LRMR Nasdaq
- Market Cap
- UIS 271.5M
- LRMR 309.8M
- IPO Year
- UIS N/A
- LRMR N/A
- Fundamental
- Price
- UIS $4.00
- LRMR $3.96
- Analyst Decision
- UIS Strong Buy
- LRMR Strong Buy
- Analyst Count
- UIS 3
- LRMR 8
- Target Price
- UIS $7.17
- LRMR $17.88
- AVG Volume (30 Days)
- UIS 666.6K
- LRMR 1.3M
- Earning Date
- UIS 10-28-2025
- LRMR 10-29-2025
- Dividend Yield
- UIS N/A
- LRMR N/A
- EPS Growth
- UIS N/A
- LRMR N/A
- EPS
- UIS N/A
- LRMR N/A
- Revenue
- UIS $1,957,800,000.00
- LRMR N/A
- Revenue This Year
- UIS N/A
- LRMR N/A
- Revenue Next Year
- UIS $3.79
- LRMR N/A
- P/E Ratio
- UIS N/A
- LRMR N/A
- Revenue Growth
- UIS N/A
- LRMR N/A
- 52 Week Low
- UIS $3.56
- LRMR $1.61
- 52 Week High
- UIS $8.93
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- UIS 51.35
- LRMR 54.10
- Support Level
- UIS $3.82
- LRMR $3.78
- Resistance Level
- UIS $4.13
- LRMR $4.26
- Average True Range (ATR)
- UIS 0.15
- LRMR 0.27
- MACD
- UIS 0.02
- LRMR -0.00
- Stochastic Oscillator
- UIS 66.67
- LRMR 55.14
About UIS Unisys Corporation New
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.